Neil Chatterji
Stock Analyst at B. Riley Securities
(1.72)
# 3,397
Out of 5,182 analysts
21
Total ratings
36.84%
Success rate
2.77%
Average return
Main Sectors:
Stocks Rated by Neil Chatterji
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLPT ClearPoint Neuro | Maintains: Buy | $18 → $20 | $11.10 | +80.18% | 6 | Mar 18, 2026 | |
| OPRX OptimizeRx | Maintains: Buy | $17 → $13 | $6.63 | +96.08% | 3 | Dec 24, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $95 → $50 | $70.99 | -29.57% | 2 | Nov 9, 2023 | |
| ARAY Accuray | Reiterates: Buy | $7.5 | $0.46 | +1,527.60% | 1 | Oct 4, 2023 | |
| ZUMZ Zumiez | Maintains: Neutral | $15 → $18 | $24.02 | -25.06% | 2 | Sep 8, 2023 | |
| KRMD KORU Medical Systems | Initiates: Buy | $4.5 | $4.08 | +10.29% | 1 | Sep 7, 2023 | |
| HYPR Hyperfine | Maintains: Buy | $2.5 → $3.5 | $1.71 | +104.68% | 3 | Aug 15, 2023 | |
| STXS Stereotaxis | Maintains: Buy | $6 → $5.5 | $1.92 | +186.46% | 2 | Mar 6, 2023 | |
| BFLY Butterfly Network | Initiates: Buy | $9.5 | $4.82 | +97.10% | 1 | Oct 4, 2022 |
ClearPoint Neuro
Mar 18, 2026
Maintains: Buy
Price Target: $18 → $20
Current: $11.10
Upside: +80.18%
OptimizeRx
Dec 24, 2024
Maintains: Buy
Price Target: $17 → $13
Current: $6.63
Upside: +96.08%
Establishment Labs Holdings
Nov 9, 2023
Maintains: Buy
Price Target: $95 → $50
Current: $70.99
Upside: -29.57%
Accuray
Oct 4, 2023
Reiterates: Buy
Price Target: $7.5
Current: $0.46
Upside: +1,527.60%
Zumiez
Sep 8, 2023
Maintains: Neutral
Price Target: $15 → $18
Current: $24.02
Upside: -25.06%
KORU Medical Systems
Sep 7, 2023
Initiates: Buy
Price Target: $4.5
Current: $4.08
Upside: +10.29%
Hyperfine
Aug 15, 2023
Maintains: Buy
Price Target: $2.5 → $3.5
Current: $1.71
Upside: +104.68%
Stereotaxis
Mar 6, 2023
Maintains: Buy
Price Target: $6 → $5.5
Current: $1.92
Upside: +186.46%
Butterfly Network
Oct 4, 2022
Initiates: Buy
Price Target: $9.5
Current: $4.82
Upside: +97.10%